Quinotolast

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H12N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SUC3551A8U, chemically known as 4h-quinolizine-3-carboxamide, 4-oxo-1-phenoxy-n-1h-tetrazol-5-yl but generally known as quinotolast, which bears US NIH Compound Identifier 65871. European Medicines Agency schedules Quinotolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10220MIG. The term QUINOTOLAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). QUINOTOLAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quinotolast under HS 29337900 and SITC 51561. As of Q4 2014, QUINOTOLAST remains the US FDA Preferred Term for this commodity. Quinotolast bears US NLM identifiers UMLS ID C0210064 and NCI Concept Code C73052. SMILES: O(C1C2N(C(=O)C(C1)C(=O)NC1N[NH]NN1)CCCC2)C1CCCCC1.